Determinants and prognostic value of kidney disease in pulmonary arterial hypertension

V. Cottin (lyon, France), L. Bitker (lyon, France), F. Sens (lyon, France), C. Payet (lyon, France), S. Turquier (lyon, France), J. Traclet (lyon, France), K. Ahmad (lyon, France), S. Zeghmar (lyon, France), J. Mornex (lyon, France), A. Duclos (lyon, France), L. Juillard (lyon, France)

Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Session: Clinical aspects of pulmonary hypertension
Session type: Thematic Poster
Number: 3089
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cottin (lyon, France), L. Bitker (lyon, France), F. Sens (lyon, France), C. Payet (lyon, France), S. Turquier (lyon, France), J. Traclet (lyon, France), K. Ahmad (lyon, France), S. Zeghmar (lyon, France), J. Mornex (lyon, France), A. Duclos (lyon, France), L. Juillard (lyon, France). Determinants and prognostic value of kidney disease in pulmonary arterial hypertension. 3089

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Towards prognostic biomarkers in pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 799-801
Year: 2012


Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 704-713
Year: 2014



Prognostic value of hemodynamics following treatment initiation in pulmonary arterial hypertension
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017



The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Prognostic significance of pulmonary arterial pressure in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012

Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 770
Year: 2009


Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013

Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Risk assessment in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 390-398
Year: 2016



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017
Year: 2018



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018
Year: 2018



Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 342s
Year: 2007

Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010